This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Charles River Laboratories International In (CRL)

NYSE: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 104.15M 97.87M 109.98M -342.12M
Operating Gains/Losses 18.68M 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -19.49M -16.27M 7.67M -5.64M
(Increase) Decrease in Inventories -1.57M 785.00K 3.77M 1.99M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -7.08M -3.26M 2.21M 71.00K
(Decrease) Increase In Other Current Liabilities 9.63M -6.39M -32.06M 5.77M
(Increase) Decrease In Other Working Capital -6.84M -915.00K -8.59M 5.36M
Other Non-Cash Items 4.32M 35.97M 27.31M 431.71M
Net Cash From Continuing Operations 207.14M 208.01M 206.84M 168.24M
Net Cash From Discontinued Operations 0.00 -106.00K -1.56M 777.00K
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 207.14M 207.90M 205.28M 169.01M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -39.15M -47.53M -49.14M -42.86M
Acquisitions -29.22M -16.86M 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 307.00K 2.79M 5.45M 950.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -74.05M -54.99M -36.64M 5.76M
Issuance of Debt 511.80M 74.12M 250.71M 579.37M
Cash Used for Financing Activities
Issuance of Capital Stock 93.79M 18.36M 20.62M 4.43M
Repayment of Long-Term Debt -523.30M -140.35M -252.96M -381.54M
Repurchase of Capital Stock -165.93M -64.19M -283.80M -356.53M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -594.00K 940.00K -6.36M -13.70M
Net Cash From Financing Activities -84.24M -111.12M -271.79M -167.90M
Effect of Exchange Rate Changes -2.61M -1.01M -7.11M -10.29M
Net Change in Cash & Cash Equivalents 46.24M 40.78M -110.26M -3.41M
CRL News

CRL Charles River Laboratories International In

Analysts Ratings for CRL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 11 12 11 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CRL ANALYST REPORT

Brokerage Partners

CRL Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs